Found 48 presentations matching your search
Extraits de la brochure institutionnelle 2010.
Antitumor antibiotics
strategy for drug design
Alkylating agents
ANGIOTENSIN CONVERTING ENZYME INHIBITOR - FUNCTION AND IMPORTANCE
This presentation developed was by David Rubin, MD, Millie Long, MD, MPH, and Anita Afzali, MD, MPH,...
What is Drug Discovery? Drug Discovery Process Pharmaceutical Development Skyrocketing Costs in Drug...
Effective pharmaceutical marketing is key to the success of the biggest pharmaceutical companies wor...
2020 Fortune 1000 list factoids and findings
The global idiopathic pulmonary fibrosis treatment market size reached US$ 3,848.3 Million in 2023. ...
The global anti-rheumatics market size reached US$ 64.5 Billion in 2023. Looking forward, IMARC Grou...
Lindstrom provides comprehensive cleanroom services. Ensure optimal contamination control with our g...
The global gastric cancer drugs market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC ...
The global ulcerative colitis market size reached US$ 7.8 Billion in 2023. Looking forward, IMARC Gr...
MONOCLONAL ANTIBODIES
Drugs used for rare disease
The Healthark team actively participated in BioAsia 2025, engaging in insightful discussions, launch...
ppt
Myeloma.pptx presnatation for newcomers
Myeloma.pptx presnatation for newcomers#1.pptx
A concise presentation on the DPP-IV inhibitor Sitagliptin an oral anti-diabetic agent. Its general ...
Quality & compliance excellence in pharmaceuticals
![Monoclonal antibodies [autosaved]](https://slidepub.com/thumb/1067/45641067.jpg)
